NACFC 2021 | S28: Clinical Advancements in Modulator Therapy

NACFC 2021 | S04: The New Era of Highly Effective CFTR Modulator TherapyПодробнее

NACFC 2021 | W31: Difficult to Treat CFTR Mutations, Novel Modulator, RNA Editing Tech to Fix CFTRПодробнее

NACFC 2021 | S21: Biomarkers & Trial Designs for Novel Cystic Fibrosis TherapiesПодробнее

NACFC 2021 | W26: Advancements in CF PharmacologyПодробнее

NACFC 2022 | W16: Updates in Cystic Fibrosis PharmacotherapyПодробнее

NACFC 2021 | W20: Update on ModulatorsПодробнее

NACFC 2021 | W28: Systems for Developing and Testing Therapeutic StrategiesПодробнее

NACFC 2021 | S20: Promoting Healthy Living in the Era of CFTR Modulators: Where Do We BeginПодробнее

NACFC 2021 | Plenary 3: Expanding the Horizon of Therapies for the Underlying Cause of CFПодробнее

NACFC 2021 | W29: Therapies Beyond CFTRПодробнее

NACFC 2021 | S18: Modulating the CFTR MoleculeПодробнее

NACFC 2022 | DG02: Wait There Is More — Hidden Effects of Highly Effective Modulator TherapyПодробнее

NACFC 2021 | W03: Hey Baby: Pregnancy in the Era of Highly Effective Modulator TherapyПодробнее

NACFC 2022 | W01: PEx in the Era of Highly Effective Modulator Therapy (HEMT):How Do We Define This?Подробнее